People with Down syndrome carry an extra copy of chromosome 21. But it has been unclear which genes within this dense package of DNA are responsible for the disorder, which includes mental retardation, early onset Alzheimer’s disease and other health problems. In a paper published today in Nature Neuroscience, researchers identified two crucial genes, called Olig1 and Olig2, involved in Down syndrome. Reducing the activity of these genes in mice engineered to mimic the disorder helps correct abnormal brain activity in these animals, a problem that is also present in people with the disorder.
“We hope the findings will lead to better strategies for early intervention, even during the pregnancy, to reduce neurological consequences of Down syndrome,” said Zygmunt Galdzicki, associate professor of Anatomy, Physiology and Genetics at Uniformed Services University of the Health Sciences, in a statement from the university. “These findings show the need to do more human studies and also suggest that Olig1 and Olig2 inhibitors may have a potential therapeutic role for Down syndrome individuals.”
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.